OCGN logo

Ocugen (OCGN)

Profile

Full Name

Ocugen, Inc.

Ticker Symbol

OCGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 3, 2014

Indexes

Not included

Website

http://www.ocugen.com

Employees

95

Key Details

Price

$0.97(-1.42%)

Market cap

$283.27M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.05M(-32.82% YoY)

Annual EPS

-$0.20(+23.08% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.97
    OCGN price is $0.97

    30-Day Relative Volume

    1.39
    OCGN 30-day relative volume is 1.39

    Price Performance

    Price Most recent change

    -1.42%
    OCGN price was down -1.42% on Jun 30, 2025

    Price YTD change

    +20.5%
    OCGN price is up +20.5% since January 1st

    Price 1-year change

    -37.42%
    OCGN price is down -37.42% year-on-year

    Price 3-year change

    -57.27%
    OCGN price is down -57.27% over the past 3 years

    Price Range

    Price All-time high

    $778.20
    OCGN price is currently -99.88% below its historical high of $778.20

    Price 3-year low

    $0.34
    OCGN price is currently +181.16% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $283.27M
    OCGN market capitalization is $283.27 million

    Market cap 3-year change

    -42.27%
    OCGN market capitalization is down -42.27% over the past 3 years

    Market cap All-time high

    $3.12B
    OCGN market capitalization is currently -90.92% below its historical high of $3.12 billion

    Market cap sector rank

    59.25%
    OCGN market capitalization is higher than 59.25% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +13.44%
    OCGN shares outstanding is up +13.44% year-on-year

    Shares Outstanding 3-Year Change

    +35.11%
    OCGN shares outstanding is up +35.11% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.45
    OCGN beta is 1.45

    200-day SMA

    $0.83
    OCGN price is currently +16.28% above its 200-day simple moving average

    50-day SMA

    $0.87
    OCGN price is currently +11.57% above its 50-day simple moving average

    RSI

    48.59
    OCGN 14-day relative strength index is 48.59

    Volume

    1.39
    OCGN 30-day relative volume is 1.39

    ATR

    $0.10
    OCGN average true range is $0.10

    10-day Historical Volatility

    62.38%
    OCGN 10-day historical volatility is 62.38%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.05M
    OCGN annual revenue is $4.05 million

    Revenue Analysts estimate

    $2.52M
    OCGN annual revenue is currently +61.20% higher than the consensus analysts' forecast

    Revenue 1-year change

    -32.82%
    OCGN annual revenue is down -32.82% year-on-year

    Revenue Sector rank

    20.14%
    OCGN annual revenue is higher than 20.14% of companies in Healthcare sector

    EPS

    EPS

    -$0.20
    OCGN annual earnings per share is -$0.20

    EPS Analysts estimate

    -$0.23
    OCGN annual earnings per share is currently -14.27% lower than the consensus analysts' forecast

    EPS 1-year change

    +23.08%
    OCGN annual earnings per share is up +23.08% year-on-year

    EPS Sector rank

    76.28%
    OCGN annual earnings per share is higher than 76.28% of companies in Healthcare sector

    Profit

    Gross profit

    -
    OCGN annual gross profit value is unknown

    Gross margin

    -
    OCGN annual gross profit margin value is unknown

    Operating profit

    -$54.76M
    OCGN annual operating income is -$54.76 million

    Operating margin

    -1350.36%
    OCGN annual operating profit margin is -1350.36%

    Net income

    -$54.05M
    OCGN annual net profit is -$54.05 million

    Net margin

    -1333.02%
    OCGN annual net profit margin is -1333.02%

    Expenses

    Total expenses

    $58.81M
    OCGN annual total expenses is $58.81 million

    Operating expenses

    $58.81M
    OCGN annual total operating expenses is $58.81 million

    Cost of goods sold

    -
    OCGN annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $26.69M
    OCGN annual SGA is $26.69 million

    Depreciation and amortization

    $1.97M
    OCGN annual depreciation & amortization is $1.97 million

    Interest expense

    -
    OCGN annual interest expense value is unknown

    Income tax

    -
    OCGN annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$54.76M
    OCGN annual earnings before interest & taxes is -$54.76 million

    EBITDA

    -$52.79M
    OCGN annual EBITDA is -$52.79 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $82.44M
    OCGN annual total assets is $82.44 million

    Non current assets

    $20.76M
    OCGN annual long term assets is $20.76 million

    Current assets

    $61.68M
    OCGN annual total current assets is $61.68 million

    Cash and cash equivalents

    $58.51M
    OCGN annual cash & cash equivalents is $58.51 million

    Accounts receivable

    -
    OCGN annual accounts receivable value is unknown

    Inventory

    -
    OCGN annual inventory value is unknown

    Liabilities

    Total liabilities

    $52.81M
    OCGN annual total liabilities is $52.81 million

    Long term liabilities

    $31.22M
    OCGN annual total long term liabilities is $31.22 million

    Current liabilities

    $21.59M
    OCGN annual total current liabilities is $21.59 million

    Accounts payable

    $4.24M
    OCGN annual accounts payable is $4.24 million

    Debt

    Total debt

    $32.50M
    OCGN annual total debt is $32.50 million

    Total debt 1-year change

    +368.28%
    OCGN annual total debt is up +368.28% year-on-year

    Long term debt

    $30.66M
    OCGN annual long term debt is $30.66 million

    Short term debt

    $1.84M
    OCGN annual short term debt is $1.84 million

    Equity & Capital

    Shareholders equity

    $29.63M
    OCGN annual stockholders equity is $29.63 million

    Book value

    $29.63M
    OCGN annual book value is $29.63 million

    Retained earnings

    -$340.22M
    OCGN annual retained earnings is -$340.22 million

    Working capital

    $40.09M
    OCGN annual working capital is $40.09 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$42.14M
    OCGN annual cash flow from operations is -$42.14 million

    Cash from operations 1-year change

    +32.09%
    OCGN annual cash flow from operations is up +32.09% year-on-year

    Cash from investing

    -$3.38M
    OCGN annual cash flow from investing activities is -$3.38 million

    Cash from investing 1-year change

    -210.01%
    OCGN annual cash flow from investing activities is down -210.01% year-on-year

    Cash from financing

    $64.86M
    OCGN annual cash flow from financing activities is $64.86 million

    Cash from financing 1-year change

    +210.61%
    OCGN annual cash flow from financing activities is up +210.61% year-on-year

    CAPEX

    CAPEX

    $3.38M
    OCGN annual capital expenditures is $3.38 million

    CAPEX 1-year change

    -67.69%
    OCGN annual capital expenditures is down -67.69% year-on-year

    Free Cash Flow

    Free cash flow

    -$45.53M
    OCGN annual free cash flow is -$45.53 million

    Free cash flow 1-year change

    +37.23%
    OCGN annual free cash flow is up +37.23% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    OCGN annual gross profit margin value is unknown

    Operating margin

    -1350.36%
    OCGN annual operating profit margin is -1350.36%

    Net margin

    -1333.02%
    OCGN annual net profit margin is -1333.02%

    ROA & ROE

    ROA

    -73.55%
    OCGN annual return on assets is -73.55%

    ROE

    -154.01%
    OCGN annual return on equity is -154.01%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    OCGN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    OCGN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    17.80
    OCGN price to book ratio is 17.80

    PB ratio Sector rank

    94.92%
    OCGN price to book ratio is higher than 94.92% of companies in Healthcare sector

    PS Ratio

    PS ratio

    62.64
    OCGN price to sales ratio is 62.64

    PS ratio Sector rank

    92.58%
    OCGN price to sales ratio is higher than 92.58% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $277.29M
    OCGN enterprise value is $277.29 million

    Enterprise value Sector rank

    59.19%
    OCGN enterprise value is higher than 59.19% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.10
    OCGN EV/EBITDA is -5.10

    EV/EBITDA Sector rank

    22.28%
    OCGN EV/EBITDA is higher than 22.28% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.86
    OCGN annual current ratio is 2.86

    Quick ratio

    -
    OCGN annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.97
    OCGN annual debt to equity ratio is 0.97

    Interest coverage ratio

    -
    OCGN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    OCGN piotroski f-score value is unknown

    Altman Z-Score

    -4.12
    OCGN altman z-score is -4.12

    Analyst ratings

    Recent major analysts updates

    May 12, 25 HC Wainwright & Co.
    Buy
    May 12, 25 Chardan Capital
    Buy
    Mar 6, 25 HC Wainwright & Co.
    Buy
    Mar 6, 25 Chardan Capital
    Buy
    Feb 13, 25 HC Wainwright & Co.
    Buy
    Feb 13, 25 Chardan Capital
    Buy
    Jan 23, 25 Chardan Capital
    Buy
    Jan 13, 25 HC Wainwright & Co.
    Buy
    Nov 18, 24 Chardan Capital
    Buy
    Nov 14, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with OCGN included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    • What is the ticker symbol for Ocugen?
    • Does Ocugen pay dividends?
    • What sector is Ocugen in?
    • What industry is Ocugen in?
    • What country is Ocugen based in?
    • When did Ocugen go public?
    • Is Ocugen in the S&P 500?
    • Is Ocugen in the NASDAQ 100?
    • Is Ocugen in the Dow Jones?
    • When was Ocugen's last earnings report?
    • When does Ocugen report earnings?
    • Should I buy Ocugen stock now?

    What is the ticker symbol for Ocugen?

    The ticker symbol for Ocugen is NASDAQ:OCGN

    Does Ocugen pay dividends?

    No, Ocugen does not pay dividends

    What sector is Ocugen in?

    Ocugen is in the Healthcare sector

    What industry is Ocugen in?

    Ocugen is in the Biotechnology industry

    What country is Ocugen based in?

    Ocugen is headquartered in United States

    When did Ocugen go public?

    Ocugen's initial public offering (IPO) was on December 3, 2014

    Is Ocugen in the S&P 500?

    No, Ocugen is not included in the S&P 500 index

    Is Ocugen in the NASDAQ 100?

    No, Ocugen is not included in the NASDAQ 100 index

    Is Ocugen in the Dow Jones?

    No, Ocugen is not included in the Dow Jones index

    When was Ocugen's last earnings report?

    Ocugen's most recent earnings report was on May 9, 2025

    When does Ocugen report earnings?

    The next expected earnings date for Ocugen is Aug 8, 2025

    Should I buy Ocugen stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page